Trial Profile
A Study Comparing The Switching Effect Of Daily Teriparatide (TPTD) To Oral Bisphosphonates (BP) And Denosumab (DMAb) In Patients With Primary Osteoporosis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Mar 2017
Price :
$35
*
At a glance
- Drugs Denosumab (Primary) ; Alendronic acid; Minodronic acid; Risedronic acid
- Indications Osteoporosis
- Focus Therapeutic Use
- 31 Mar 2017 New trial record